One-size-fits-all is no fit for heart health

From Weight Watchers to wearable tech – wherever we look, there are messages encouraging us to stay fit and healthy. But diets and training methods aside, when it comes to heart health, research from the University of South Australia shows that a far more personalised approach is needed…and it all starts with your genes.

Hopelessness in heart patients study to factor in COVID-19

A University of Illinois Chicago research study on how to improve care for heart disease patients struggling with hopelessness has been supplemented by the National Institutes of Health, or NIH, to determine whether the study intervention called “Heart Up!” limits the negative impact of COVID-19 shelter-in-place and physical distancing measures on health outcomes.

Largest pharmacogenetic clinical trial in cardiology shows potential benefit in individualized approach to anti-platelet therapy

ROCHESTER, Minn. ― Heart patients who undergo percutaneous coronary intervention (PCI) or stent placement― nonsurgical procedures to improve blood flow to the heart ― are typically prescribed anti-platelet therapy to avoid blood clots that can lead to a heart attack or stroke. New research from the international TAILOR-PCI trial, the largest pharmacogenetics clinical trial in cardiology, suggests that genetic testing could potentially be a useful tool to help select antiplatelet medication. Pharmacogenetics is the use of a patient’s genetic makeup in prescribing treatments that are likely to be most successful.

Study Shows Socioeconomic Status Linked to Heart Failure Mortality in United States

A variety of treatments exist to address heart disease, yet it continues to carry a poor prognosis. A new study from University Hospitals showed that a person’s address can help predict their chance of mortality from heart disease.

Baylor Scott & White Health Again Recognized as Most Awarded Not-for-profit Health System in Texas by U.S. News & World Report

In the midst of the extraordinary health challenge presented by the COVID-19 pandemic, Baylor Scott & White Health remains committed to quality, safe care and helping Texas communities navigate the uncertainty of the SARS-CoV-2 virus. Today, this commitment to safety and quality is recognized as U.S. News & World Report releases its 2020-2021 Best Hospitals list.

University of Miami Launches COVID-19 Heart Program

A new COVID-19 Heart Program developed by cardiologists with the University of Miami Miller School of Medicine is addressing the varied heart issues stemming from the pandemic with comprehensive screenings and evaluations in a safe clinical setting. It also incorporates the latest findings from UM cardiology researchers studying how the coronavirus can affect the heart and its surrounding tissues.

MacNeal Hospital Launches First Clinical Trial in Illinois of Novel Monitoring Device for Congestive Heart Failure Patients

MacNeal Hospital is the first hospital in Illinois to participate in a national, randomized clinical trial using daily vital signs and lung pressure measurement to manage patients with congestive heart failure (CHF). The PROACTIVE-HF trial utilizes a new monitoring system, coupled with a pressure sensor, implanted directly into a blood vessel in the lung. This system provides information that is recorded and transmitted over a cellular or Wi-Fi connection to a patient’s provider, allowing for medication changes, if necessary, to prevent further health deterioration or hospitalization.

Foxglove plants produce heart medicine. Can science do it better?

Biologist Zhen Wang’s team recently published a pair of papers detailing characteristics of cardiac glycosides in two foxglove species. “This kind of study is important because we first have to know the accurate structure of natural compounds before we can explore their medicinal effects,” she says.

Mayo researchers create, test AI to improve EKG testing for hypertrophic cardiomyopathy

An approach based on artificial intelligence (AI) may allow EKGs to be used to screen for hypertrophic cardiomyopathy in the future. With hypertrophic cardiomyopathy, the heart walls become thick and may interfere with the heart’s ability to function properly. The disease also predisposes some patients to potentially fatal abnormal rhythms. Current EKG technology has limited diagnostic yield for this disease.

Mayo Clinic study looks at changes in patient characteristics, outcomes for coronary revascularization over 14-year period

The most common type of heart disease ― coronary artery disease ― affects 6.7% of adults and accounts for 20% of 2 in 10 deaths of adults under age 65. The condition builds over time as inflammation and cholesterol-containing plaques settle in the heart’s arteries, where they can eventually cause narrowing and blockages that lead to a heart attack.

Intermittent Fasting Increases Longevity in Cardiac Catheterization Patients

In a new study by researchers at the Intermountain Healthcare Heart Institute in Salt Lake City, researchers have found that cardiac catheterization patients who practiced regular intermittent fasting lived longer than patients who don’t.

Developing Electrically Active Materials to Repair Damaged Hearts

When a heart attack occurs, muscle in the heart tissue can be scarred, interfering with electrical activity necessary for healthy heart function. Using artificial materials to patch or rebuild damaged parts has been tried but only recently has work focused on the electrical properties needed for proper cardiac operation. In this week’s APL Bioengineering, investigators review the use of electrically conductive biomaterials for heart repair and treatment.

University of Michigan Expert Available: Study Cautions Against Catch-All Assumptions about LVADs and Mitral Regurgitation

ANN ARBOR, Mich. — Mitral valve procedures are often not performed because of the standing belief that LVAD support resolves mitral regurgitation, due to better left heart performance. A new study in The Journal of Thoracic and Cardiovascular Surgery found when…